Insights on Low Platelet Count from Anshul Gupta – Aastha Hospice
Aastha Hospice shared a post on X:
“Understanding Low Platelet Count: Insights from Dr. Anshul Gupta, Senior Hemato-Oncologist.
Low platelet count (thrombocytopenia) is a common cause of panic among patients.
In a discussion with Dr. Abhishek Shukla, Dr. Anshul Gupta, Senior Hemato-Oncologist, provided key clinical perspectives on managing this condition.
When evaluating a patient with low platelets, doctors consider three primary factors:
- Age: Special attention is required for children (younger than 18 years) and elderly individuals (older than 60 years), where a low count might indicate underlying conditions or bone marrow issues rather than simple Immune Thrombocytopenia (ITP).
- Clinical Appearance: Assessing whether the patient looks acutely ill or remains symptomatic-free and mobile.
- Complete Blood Count (CBC) Profile: Checking whether other blood cell lines (WBCs and Hemoglobin) are also affected.
In ITP or post-viral cases (like Dengue), counts above 30,000 generally do not require immediate intervention, as antibody levels usually subside over time. If platelets drop below 20,000 or bleeding occurs (e.g., from the mouth, nose, or in urine), prompt evaluation and possible admission are needed.
In Dengue, repetitive platelet transfusions are often unnecessary unless clinically indicated. Regarding treatment, popular remedies like Carica papaya extract lack definitive clinical evidence.
While specific medications such as Eltrombopag or Romiplostim exist to raise platelet counts, they must be used strictly under expert guidance; unnecessary use can cause dangerously high platelet levels and severe risks like arterial thrombosis.
Key Takeaway:
Do not panic over a low report. Consult a physician or hematologist to treat the underlying cause rather than self-medicating.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series